German Oncology Center, Cyprus
11
6
7
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)
Role: lead
Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer
Role: lead
Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)
Role: lead
Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate Cancer
Role: lead
Clinical Evaluation of the NeoPill Device for Reduction of Oral Bacterial Load in Patients With Fixed Orthodontic Appliances
Role: collaborator
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
Role: collaborator
Testing and Evaluating the Collection of Patient Reported Outcomes In Cancer Care Using Innovative Approaches
Role: collaborator
Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus
Role: collaborator
The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia
Role: collaborator
Multimodal Program for Cancer Related Cachexia Prevention
Role: collaborator
The Effectiveness of a Thyme and Honey Spray for Oral Toxicities
Role: collaborator
All 11 trials loaded